-
1
-
-
0029049688
-
Good practice with endometrial ablation
-
Garry R. Good practice with endometrial ablation. Obst Gynaecol 1995 85 : 144 51.
-
(1995)
Obst Gynaecol
, vol.85
, pp. 144-51
-
-
Garry, R.1
-
2
-
-
84900943592
-
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding (Cochrane Review)
-
In: Oxford, UK: Update Software
-
Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding (Cochrane Review). In : The Cochrane Library. Oxford, UK : Update Software 2003.
-
(2003)
The Cochrane Library.
-
-
Sowter, M.C.1
Lethaby, A.2
Singla, A.A.3
-
3
-
-
0028306250
-
Gonadotropin-releasing hormone and its analogs
-
Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994 45 : 391 405.
-
(1994)
Annu Rev Med
, vol.45
, pp. 391-405
-
-
Conn, P.M.1
Crowley Jr., W.F.2
-
4
-
-
0029949201
-
A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation
-
Garry R, Khair A, Mooney P, Stuart M. A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation. Br J Obstet Gynaecol 1996 103 : 339 44.
-
(1996)
Br J Obstet Gynaecol
, vol.103
, pp. 339-44
-
-
Garry, R.1
Khair, A.2
Mooney, P.3
Stuart, M.4
-
5
-
-
0035944837
-
Gonadotropin-releasing hormone receptor antagonists. New drug classes
-
Huirne JAF, Lambalk CB. Gonadotropin-releasing hormone receptor antagonists. New drug classes. Lancet 2001 358 : 1793 803.
-
(2001)
Lancet
, vol.358
, pp. 1793-803
-
-
Huirne, J.A.F.1
Lambalk, C.B.2
-
6
-
-
0030730449
-
Treatment of uterine leiomyomas with luteinising hormone-releasing hormone antagonist cetrorelix
-
Gonzalez-Barcena D, Alvarez RB, Ochoa EP, et al. Treatment of uterine leiomyomas with luteinising hormone-releasing hormone antagonist cetrorelix. Hum Reprod 1997 12 : 2028 35.
-
(1997)
Hum Reprod
, vol.12
, pp. 2028-35
-
-
Gonzalez-Barcena, D.1
Alvarez, R.B.2
Ochoa, E.P.3
-
7
-
-
0007003397
-
Initial safety profile and hormonal dose-response characteristics of the pure GnRH antagonist, abarelix-depot, in women with endometriosis
-
(abstract).
-
Martha PM, Gray ME, Campion M, et al. Initial safety profile and hormonal dose-response characteristics of the pure GnRH antagonist, abarelix-depot, in women with endometriosis. Gynaecol Endocrinol 1999 13 : 104 (abstract).
-
(1999)
Gynaecol Endocrinol
, vol.13
, pp. 104
-
-
Martha, P.M.1
Gray, M.E.2
Campion, M.3
-
8
-
-
0034047072
-
Inhibitory effect of luteinising-releasing hormone analogues on human endometrial cancer in vitro
-
Noci I, Coronnello M, Borri P, et al. Inhibitory effect of luteinising-releasing hormone analogues on human endometrial cancer in vitro. Cancer Lett 2000 150 : 71 8.
-
(2000)
Cancer Lett
, vol.150
, pp. 71-8
-
-
Noci, I.1
Coronnello, M.2
Borri, P.3
-
9
-
-
0028283353
-
Suppression of the endogenous luteinising hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation
-
Diedrich K, Diedrich C, Santos E, et al. Suppression of the endogenous luteinising hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Human Reprod 1994 9 : 788 91.
-
(1994)
Human Reprod
, vol.9
, pp. 788-91
-
-
Diedrich, K.1
Diedrich, C.2
Santos, E.3
-
10
-
-
0028038145
-
Single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilisation embryo transfer program
-
Olivennes F, Franchin R, Bouchard P, et al. Single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilisation embryo transfer program. Fertil Steril 1994 62 : 468 76.
-
(1994)
Fertil Steril
, vol.62
, pp. 468-76
-
-
Olivennes, F.1
Franchin, R.2
Bouchard, P.3
-
11
-
-
17544399958
-
Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: A prospective uncontrolled phase III study
-
Felberbaum RE, Albano C, Ludwig M, et al. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 2000 15 : 1015 20.
-
(2000)
Hum Reprod
, vol.15
, pp. 1015-20
-
-
Felberbaum, R.E.1
Albano, C.2
Ludwig, M.3
-
12
-
-
0034053260
-
Ovarian stimulation with HMG: Results of a prospective randomised phase III European study comparing the luteinising hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin
-
Albano C, Felberbaum RE, Smitz J, et al. Ovarian stimulation with HMG: results of a prospective randomised phase III European study comparing the luteinising hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 2000 15 : 526 31.
-
(2000)
Hum Reprod
, vol.15
, pp. 526-31
-
-
Albano, C.1
Felberbaum, R.E.2
Smitz, J.3
-
13
-
-
0031661436
-
The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: A dose finding study of 3 versus 2 mg
-
Olivennes F, Alvarez S, Bouchard P, et al. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod 1998 13 : 2411 14.
-
(1998)
Hum Reprod
, vol.13
, pp. 2411-14
-
-
Olivennes, F.1
Alvarez, S.2
Bouchard, P.3
-
14
-
-
0035142762
-
Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women
-
Erb K, Klipping C, Duijkers I, et al. Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women. Fertil Steril 2001 75 : 316 23.
-
(2001)
Fertil Steril
, vol.75
, pp. 316-23
-
-
Erb, K.1
Klipping, C.2
Duijkers, I.3
-
15
-
-
0037561013
-
Cetrotide International Study Groups. Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing LH surges: Report of two large multicentre, multinational, phase IIIb clinical experiences
-
Olivennes F, Diedrich K, Frydman R, et al. Cetrotide International Study Groups. Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences. Reprod Biomed Online 2003 6 : 432 8.
-
(2003)
Reprod Biomed Online
, vol.6
, pp. 432-8
-
-
Olivennes, F.1
Diedrich, K.2
Frydman, R.3
-
16
-
-
0033816489
-
Is endometrial pre-treatment of value in improving the outcome of trans-cervical resection of the endometrium?
-
Rai VS, Gillmer MDG, Gray W. Is endometrial pre-treatment of value in improving the outcome of trans-cervical resection of the endometrium? Hum Reprod 2000 15 : 1989 92.
-
(2000)
Hum Reprod
, vol.15
, pp. 1989-92
-
-
Rai, V.S.1
Gillmer, M.D.G.2
Gray, W.3
-
17
-
-
0343632342
-
Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: A large randomised, double blind study
-
Donnez J, Vilos G, Gannon MJ, et al. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomised, double blind study. Fertil Steril 1997 68 : 29 6.
-
(1997)
Fertil Steril
, vol.68
, pp. 29-6
-
-
Donnez, J.1
Vilos, G.2
Gannon, M.J.3
-
18
-
-
20244374949
-
Scottish Hysteroscopy Audit Group. a Scottish audit of hysteroscopic surgery for menorrhagia: Complications and follow up
-
Kitchener HC. Scottish Hysteroscopy Audit Group. A Scottish audit of hysteroscopic surgery for menorrhagia: complications and follow up. Br J Obstet Gynaecol : 1995 102 : 249 54.
-
(1995)
Br J Obstet Gynaecol
, vol.102
, pp. 249-54
-
-
Kitchener, H.C.1
-
20
-
-
0030712967
-
A national survey of the complications of endometrial destruction for menstrual disorders: The MISTLETOE study. Minimally Invasive Surgical Techniques-Laser, EndoThermal or Endoresection
-
Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Minimally Invasive Surgical Techniques-Laser, EndoThermal or Endoresection. Br J Obstet Gynaecol 1997 104 : 1351 9.
-
(1997)
Br J Obstet Gynaecol
, vol.104
, pp. 1351-9
-
-
Overton, C.1
Hargreaves, J.2
Maresh, M.3
|